MDM2 and chronic myelogenous leukemia, BCR-ABL1 positive: Analysis of editing rates in individual samples from our RNA-seq dataset [1] showed increased RNA editing of MDM2, APOBEC3D, and AZIN1 in BC CML LSC compared with CP progenitors (Figure 1B-D).